杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/06/06 | 1,620 | 1,630 | 1,606 | 1,624 | +17 | +1.1% | 128,000 |
| 2012/06/05 | 1,622 | 1,623 | 1,584 | 1,607 | -27 | -1.7% | 248,000 |
| 2012/06/04 | 1,598 | 1,647 | 1,598 | 1,634 | +12 | +0.7% | 172,000 |
| 2012/06/01 | 1,632 | 1,650 | 1,605 | 1,622 | +2 | +0.1% | 300,000 |
| 2012/05/31 | 1,539 | 1,620 | 1,537 | 1,620 | +52 | +3.3% | 372,000 |
| 2012/05/30 | 1,540 | 1,575 | 1,533 | 1,568 | +11 | +0.7% | 162,000 |
| 2012/05/29 | 1,556 | 1,574 | 1,533 | 1,557 | +1 | +0.1% | 153,000 |
| 2012/05/28 | 1,582 | 1,583 | 1,553 | 1,556 | -42 | -2.6% | 104,000 |
| 2012/05/25 | 1,584 | 1,605 | 1,582 | 1,598 | +37 | +2.4% | 216,000 |
| 2012/05/24 | 1,564 | 1,580 | 1,556 | 1,561 | -2 | -0.1% | 88,000 |
| 2012/05/23 | 1,572 | 1,577 | 1,557 | 1,563 | -16 | -1% | 149,000 |
| 2012/05/22 | 1,579 | 1,601 | 1,579 | 1,579 | +1 | +0.1% | 151,000 |
| 2012/05/21 | 1,561 | 1,586 | 1,559 | 1,578 | +17 | +1.1% | 127,000 |
| 2012/05/18 | 1,579 | 1,603 | 1,554 | 1,561 | -33 | -2.1% | 369,000 |
| 2012/05/17 | 1,604 | 1,625 | 1,578 | 1,594 | -25 | -1.5% | 463,000 |
| 2012/05/16 | 1,600 | 1,619 | 1,579 | 1,619 | +20 | +1.3% | 172,000 |
| 2012/05/15 | 1,584 | 1,614 | 1,574 | 1,599 | +15 | +0.9% | 151,000 |
| 2012/05/14 | 1,621 | 1,624 | 1,577 | 1,584 | -47 | -2.9% | 270,000 |
| 2012/05/11 | 1,669 | 1,675 | 1,627 | 1,631 | -34 | -2% | 302,000 |
| 2012/05/10 | 1,583 | 1,679 | 1,579 | 1,665 | +103 | +6.6% | 309,000 |
| 2012/05/09 | 1,528 | 1,595 | 1,504 | 1,562 | +39 | +2.6% | 148,000 |
| 2012/05/08 | 1,515 | 1,532 | 1,510 | 1,523 | -11 | -0.7% | 83,000 |
| 2012/05/07 | 1,535 | 1,550 | 1,524 | 1,534 | -43 | -2.7% | 101,000 |
| 2012/05/02 | 1,565 | 1,580 | 1,556 | 1,577 | +32 | +2.1% | 96,000 |
| 2012/05/01 | 1,540 | 1,557 | 1,535 | 1,545 | +7 | +0.5% | 87,000 |
| 2012/04/27 | 1,531 | 1,550 | 1,518 | 1,538 | -8 | -0.5% | 72,000 |
| 2012/04/26 | 1,547 | 1,564 | 1,538 | 1,546 | -8 | -0.5% | 95,000 |
| 2012/04/25 | 1,560 | 1,569 | 1,544 | 1,554 | +11 | +0.7% | 70,000 |
| 2012/04/24 | 1,527 | 1,557 | 1,527 | 1,543 | +16 | +1% | 101,000 |
| 2012/04/23 | 1,541 | 1,546 | 1,511 | 1,527 | +12 | +0.8% | 99,000 |
| 2012/04/20 | 1,517 | 1,536 | 1,515 | 1,515 | -2 | -0.1% | 107,000 |
| 2012/04/19 | 1,510 | 1,559 | 1,505 | 1,517 | +15 | +1% | 219,000 |
| 2012/04/18 | 1,491 | 1,503 | 1,489 | 1,502 | +11 | +0.7% | 79,000 |
| 2012/04/17 | 1,503 | 1,503 | 1,475 | 1,491 | +1 | +0.1% | 107,000 |
| 2012/04/16 | 1,475 | 1,500 | 1,475 | 1,490 | +7 | +0.5% | 37,000 |
| 2012/04/13 | 1,470 | 1,488 | 1,464 | 1,483 | +13 | +0.9% | 66,000 |
| 2012/04/12 | 1,483 | 1,483 | 1,460 | 1,470 | +5 | +0.3% | 117,000 |
| 2012/04/11 | 1,458 | 1,473 | 1,452 | 1,465 | -10 | -0.7% | 77,000 |
| 2012/04/10 | 1,467 | 1,475 | 1,459 | 1,475 | +8 | +0.5% | 59,000 |
| 2012/04/09 | 1,457 | 1,484 | 1,457 | 1,467 | -16 | -1.1% | 67,000 |
| 2012/04/06 | 1,481 | 1,492 | 1,478 | 1,483 | -12 | -0.8% | 58,000 |
| 2012/04/05 | 1,499 | 1,500 | 1,479 | 1,495 | -5 | -0.3% | 95,000 |
| 2012/04/04 | 1,524 | 1,530 | 1,497 | 1,500 | -24 | -1.6% | 99,000 |
| 2012/04/03 | 1,568 | 1,568 | 1,517 | 1,524 | -45 | -2.9% | 147,000 |
| 2012/04/02 | 1,568 | 1,577 | 1,563 | 1,569 | +2 | +0.1% | 150,000 |
| 2012/03/30 | 1,551 | 1,575 | 1,551 | 1,567 | +4 | +0.3% | 84,000 |
| 2012/03/29 | 1,527 | 1,584 | 1,527 | 1,563 | +18 | +1.2% | 157,000 |
| 2012/03/28 | 1,536 | 1,549 | 1,496 | 1,545 | -26 | -1.7% | 93,000 |
| 2012/03/27 | 1,563 | 1,580 | 1,563 | 1,571 | +8 | +0.5% | 106,000 |
| 2012/03/26 | 1,556 | 1,579 | 1,556 | 1,563 | -7 | -0.4% | 105,000 |
3051～
3100
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
